Think of your endometrium—the lining of your uterus—as a host. For a successful pregnancy to occur, the host must be prepared to welcome an embryo. There is a very specific, short window of time each month when the lining is biologically prepared for an embryo to attach. This state of readiness is what we call endometrial receptivity.
What is an Endometrial Receptivity Test?
An endometrial receptivity test is a diagnostic tool used to determine if your uterine lining is in that receptive state. It’s a way for your medical team to look beyond the surface and evaluate whether the environment is truly receptive for an embryo to take root before proceeding with a transfer.
Why Endometrial Receptivity Is Critical for IVF Success
Successful implantation is a partnership between a healthy embryo and a receptive uterus. If an embryo is transferred when the environment is sub-optimal, the cycle can fail.
By assessing receptivity, your medical team can confirm whether your body has reached the necessary state for implantation. This allows your doctor to make a more informed decision about your transfer, protecting the embryo from being placed in a non-receptive environment.
Types of Endometrial Receptivity Tests
Endometrial Receptivity Array (ERA)
The ERA has been a common method for evaluating the endometrium for several years. It works by taking a small physical sample (a biopsy) of your uterine lining during a “mock” cycle—a cycle where no transfer actually happens—and analyzing the genes within that tissue to estimate timing for a future cycle. Unlike newer approaches, it relies on identifying whether the lining falls within a predicted receptive window.
Non-Invasive Endometrial Receptivity Testing
Then there’s the new frontier: non-invasive testing. This is where technology like AIM comes in. Instead of a biopsy, AIM uses advanced artificial intelligence (AI) and machine learning to analyze 3D ultrasound images from your actual treatment cycle in real time.
How Endometrial Receptivity Tests Work
Invasive Testing (Biopsy-based / ERA)
With invasive tests, you will go through a mock cycle where you take all the usual transfer medications, but instead of a transfer, your doctor performs a biopsy of the lining. The results are then used to estimate the state of your lining for a future cycle.
Non-Invasive Testing with AIM Fertility
With AIM, the receptivity assessment happens during your actual transfer cycle. Your clinic performs a standard 2D ultrasound, and those images are analyzed by our AI to generate an endometrial receptivity score in near real-time. This allows your doctor to determine your body’s readiness for a transfer right now.
What Is an Endometrial Receptivity Score?
When the AIM test is done, you’ll get a score. This is essentially your status report. It gives your medical team a real-time understanding of whether your endometrium is ready for an embryo transfer in that moment.
How AIM Test Results Are Used
Unlike traditional methods that categorize timing into predefined windows, an AIM score is used to support a clear clinical decision:
- If the score confirms readiness, your doctor can proceed with the embryo transfer with greater confidence.
- If the score indicates the endometrial environment is not yet optimal, you and/or your team may decide not to transfer, helping protect the embryo for a future cycle when the endometrium is better prepared.
Benefits of Endometrial Receptivity Testing
The most significant benefit is increasing the likelihood of a successful pregnancy by avoiding sub-optimal uterine conditions. But it’s also about peace of mind. Testing helps protect your embryos by ensuring they are transferred only when your body has confirmed its biological readiness.
Limitations of Traditional Tests and the Need for Real-Time Alternatives
Traditional biopsy-based tests are invasive and rely on the assumption that your body will behave exactly the same way in a future month as it did during the “mock” cycle. However, cycles can vary. Non-invasive testing allows for a real-time assessment of your current cycle, providing a more accurate picture of how your body is responding to treatment right now.
How AIM Fertility Improves Endometrial Receptivity Testing
AIM uses Artificial Intelligence to detect subtle patterns in your lining that indicate receptivity without the need for an invasive biopsy. It’s faster, more comfortable, and built on decades of validated clinical research.
Who Should Consider an Endometrial Receptivity Test?
Because AIM is currently the only non-invasive test that accurately assesses endometrial receptivity in real time, every patient going through an IVF cycle can benefit. While it is especially valuable for those who have experienced previous failed transfers or those with a limited number of embryos, the ability to confirm readiness in every cycle provides a data-driven advantage for all IVF patients.
FAQs
Is an endometrial receptivity test painful?
If you choose a non-invasive test like AIM, not at all—it feels just like a routine ultrasound. Biopsy-based tests typically cause cramping and physical discomfort.
How accurate is an endometrial receptivity test?
Tests like AIM are developed and validated using thousands of clinical images, showing high performance in identifying the biological markers of endometrial readiness.
Can receptivity testing impact IVF outcomes?
Yes. By ensuring the embryo is transferred when the environment is receptive, testing helps reduce the risk of failed transfers due to sub-optimal uterine conditions.
How long does it take to get receptivity test results?
Biopsy results can take a week or more, requiring the delay of a transfer. Non-invasive tests like AIM provide results in near real-time, allowing your clinic to make a decision within the same treatment cycle.